Loading...
XKRX
200130
Market cap161mUSD
Jul 10, Last price  
8,440.00KRW
1D
1.69%
1Q
-26.42%
Jan 2017
-54.50%
IPO
49.38%
Name

KolmarBNH Co Ltd

Chart & Performance

D1W1MN
XKRX:200130 chart
P/E
P/S
0.43
EPS
Div Yield, %
4.61%
Shrs. gr., 5y
-0.08%
Rev. gr., 5y
-1.08%
Revenues
574.88b
-6.62%
125,141,436,000173,932,349,000236,186,775,000256,009,785,000337,569,055,000386,365,759,000438,905,518,000606,891,551,000593,080,732,000575,902,994,000579,551,538,000615,642,005,000574,884,892,000
Net income
-19.60b
L
13,121,445,00020,983,519,0001,130,065,00029,707,525,00045,771,716,00048,352,740,00054,484,240,00080,484,423,00069,866,436,00040,512,833,00019,709,710,00018,052,525,000-19,595,956,000
CFO
37.90b
-3.30%
-424,305,38717,309,961,70720,684,402,05253,319,627,66122,045,062,46478,203,594,00077,090,165,00071,939,580,0005,325,746,00056,282,493,00039,195,695,00037,903,213,000
Dividend
Aug 28, 202575 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Kolmar BNH Co., Ltd., a South Korean entity, dedicates its efforts to the research and development of cosmetics, health-enhancing functional foods, and advanced functional ingredients, serving both domestic and international markets. Their extensive product portfolio encompasses vitamins and minerals, weight management solutions, sports and nutritional supplements, gut health formulations, and various other offerings tailored for both men and women. Founded in 2004, the company was initially known as Sun Bio Tech before rebranding as Kolmar BNH Co., Ltd. in 2013. Headquartered in Sejong, South Korea, it operates as a subsidiary of Kolmar Korea Holdings Co., Ltd.
IPO date
Jul 23, 2014
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT